P4‐200: INTRANASAL FORMULATION OF ERYTHROPOIETIN (EPO) SHOWED POTENT PROTECTIVE ACTIVITY AGAINST AMYLOID TOXICITY IN NON‐TRANSGENIC AND TRANSGENIC MOUSE MODELS OF ALZHEIMER'S DISEASE. (1st July 2014)